COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,891 Articles (22,568 medRxiv, 8,323 bioRxiv)

Most recent first Previous |  Page 1942: Articles 19411-19420  | Next

Surface proteins of SARS-CoV-2 drive airway epithelial cells to induce interferon-dependent inflammation
Anand, G., Perry, A. M., Cummings, C. L., Raymond, E. S., Clemens, R. A., Steed, A. L.
10.1101/2020.12.14.422710 — Posted: 2020-12-14
Neuroinvasion and encephalitis following intranasal inoculation of SARS-CoV-2 in K18-hACE2 mice
Kumari, P., Rothan, H. A., Natekar, J. P., Stone, S., Pathak, H., Strate, P. G., Arora, K., Brinton, M. A., Kumar, M.
10.1101/2020.12.14.422714 — Posted: 2020-12-14
Computational Analysis of Dynamic Allostery and Control in the three SARS-CoV-2 non-structural proteins
Dubanevics, I., Heaton, C., Riechmann, C., McLeish, T. C. B.
10.1101/2020.12.12.422477 — Posted: 2020-12-14
Hepatitis C Virus Drugs Simeprevir and Grazoprevir Synergize with Remdesivir to Suppress SARS-CoV-2 Replication in Cell Culture
Bafna, K., White, K., Harish, B., Rosales, R., Ramelot, T. A., Acton, T. B., Moreno, E., Kehrer, T., Royer, C. A., Garcia-Sastre, A., Krug, R. M., Montelione, G. T.
10.1101/2020.12.13.422511 — Posted: 2020-12-14
Identification of bis-benzylisoquinoline alkaloids as SARS-CoV-2 entry inhibitors from a library of natural products in vitro
He, C.-L., Huang, L.-Y., Wang, K., Gu, C.-J., Hu, J., Zhang, G.-J., Xu, W., Xie, Y.-H., Tang, N., Huang, A.-L.
10.1101/2020.12.13.420406 — Posted: 2020-12-14
Profiling of oral microbiota and cytokines in COVID-19 patients
Iebba, V., Zanotta, N., Campisciano, G., Zerbato, V., Di Bella, S., Cason, C., Morassut, S., Luzzati, R., Confalonieri, M., Palamara, A. T., Comar, M.
10.1101/2020.12.13.422589 — Posted: 2020-12-14
Vaccines that prevent SARS-CoV-2 transmission may prevent or dampen a spring wave of COVID-19 cases and deaths in 2021
Swan, D. A., Goyal, A., Bracis, C., Moore, M., Krantz, E., Brown, E. R., Cardozo-Ojeda, F., Reeves, D. B., Gao, F., Gilbert, P. B., Corey, L., Cohen, M. S., Janes, H., Dimitrov, D., Schiffer, J. T.
10.1101/2020.12.13.20248120 — Posted: 2020-12-14 Discussion: Onsite
Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials
Follmann, D., Fintzi, J., Fay, M. P., Janes, H. E., Baden, L., El Sahly, H., Fleming, T. R., Mehrotra, D. V., Carpp, L. N., Juraska, M., Benkeser, D., Donnell, D., Fong, Y., Han, S., Hirsch, I., Huang, Y., Huang, Y., Hyrien, O., Luedtke, A., Carone, M., Nason, M., Vandebosch, A., Zhou, H., Cho, I., Gabriel, E., Kublin, J. G., Cohen, M. S., Corey, L., Gilbert, P. B., Neuzil, K. M.
10.1101/2020.12.14.20248137 — Posted: 2020-12-14
Unique predictors of intended uptake of a COVID-19 vaccine
Lennon, R. P., Small, M. L., Smith, R. A., Van Scoy, L. J., Myrick, J. G., Martin, M. A., Data4Action Research Group
10.1101/2020.12.11.20235838 — Posted: 2020-12-14
Association of University Reopening Policies with New Confirmed COVID-19 Cases in the United States
Li, Y., Ma, C., Tang, W., Zhang, X., Zhu, J., Nallamothu, B.
10.1101/2020.12.11.20247353 — Posted: 2020-12-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).